Resources for Researchers & Startups

COVID-19 technology?

Our online portal is open and ready.
Disclose now

We have seen our inventors and entrepreneurs rise to the challenges brought by COVID-19 this past year, and we are thankful and proud of each one of you. We at UF Innovate are here to facilitate your efforts as you continue to invent, create entrepreneurial solutions, and do all you can to change the world for the better. We hope this page of resources and stories about how UF Innovate research and entrepreneurs are doing their part to help in this pandemic encourages and inspires you.

Contact us.


Apply Here

illustration of money

Small business owners can apply for a First Draw Loan from the Payroll Protection Program by the U.S. Small Business Administration. Applications still open.


Grants & Funding

image of the coronavirus, COVID-19

Looking for program development and funding opportunities during COVID-19? Visit UF’s Emerging Pathogen’s Funding webpage to learn about available grants.


Latest UF Research

two beakers depicting research

UF researchers continue to respond to the COVID-19 crisis by doing what they do best — finding answers and solutions. Read the latest research here.


Loan Guidelines

flag of the United States of America

The U.S. Chamber of Commerce continues to help companies stay afloat and keep paychecks flowing and more. Details on relief package and vaccines here.


CORD-19 Dataset

Help generate new insights to fight COVID-19, collaborate with other researchers worldwide, participate in the CORD-19 Challenge. Learn more.


UF Health Facts

Get the fast facts about UF Health’s responses and learn about the work our researchers conduct to combat the global pandemic. The latest here.


Startup Advice

logo for Osage University Partners, a venture capital firmDo you have an idea for a startup? OUP’s tech and life sciences teams are offering free VC office hours to UF researchers. Sign up for a 30-minute complimentary session.


Funding Innovation

illustration of a microscope

The Bill & Melinda Gates Foundation pledges millions to fund innovation that tackles COVID-19 challenges. Get the latest here.


Impact on Research

logo for University of Florida Research

The coronavirus is a challenge impacting researchers at the university. UF Research is doing its best to keep researchers updated. More here.

UF Innovate Tech & Startups Aid the Fight

Research Underway To Treat COVID-19 Long Hauler Syndrome

In this article, UF Innovate | Sid Martin Biotech resident client Neobiosis founder Ian White explains how his company is using regenerative medicine to develop products to treat coronavirus long hauler syndrome. (Note: the University of Florida Innovate Center mentioned in the story should be UF Innovate | Sid Martin Biotech.)

New Resident Client at Sid Martin Biotech to Pave Way for Post-COVID Therapy, Regenerative Medicine Research

The inflammation COVID-19 patients suffer during and post-COVID-19 infection (AKA "Post-COVID Syndrome") will be one of many focuses of a new resident client that recently joined the UF Innovate | Sid Martin Biotech, the world-recognized leader in biotechnology incubation. Neobiosis, which produces regenerative tissues, cells, and extracellular vesicles for research and clinical trials to help the body heal itself—without surgery—will operate a laboratory at the biotech center, located in Alachua.

Algernon Pharmaceuticals Receives Green Light from DSMB to Conduct Phase 3 Study of Ifenprodil for COVID-19

UF startup Algernon Pharmaceuticals Inc., formerly known as Breathtec Biomedical, a clinical-stage pharmaceutical development company, announced that the external Data and Safety Monitoring Board (“DSMB”) has completed its latest review of the Phase 2b part of the Company’s Phase 2b/3 human study of NP-120 (Ifenprodil) for the treatment of COVID-19, and has provided approval for the company to continue on with the Phase 3 part of the study.

Pandemic a Boon for Area’s Biotech Industry

While industries like airlines, hospitality and retail struggled much of 2020, one local sector took off during the COVID-19 pandemic. Alachua’s biotechnology industry, anchored by startups mostly contained in one section of town off U.S. 441, contributed more than $1 billion to the local economy last year, aided in part...
Read More

Smell Tests Evaluated As Potential Tool To Identify COVID-19

A team of University of Florida neuroscientists will analyze two different smell tests under a National Institutes of Health grant aimed at developing inexpensive, at-home tests to help identify new cases of COVID-19 and provide a warning sign of a community outbreak in time to thwart it.

COVID-19 Fighting Antibodies Developed in Alachua Sent to Clinical Trials

Supporting our troops: an Alachua company works to keep our soldiers safe from COVID-19. Here's what UF startup and UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), is doing on the front lines of the pandemic.

Ology Bioservices Signs Built-to-Suit Lab Space, Adding 43,000 Square Feet to Headquarters

Avison Young facilitated a 42,500-square-foot lease agreement between Concept Companies and Ology Bioservices, a UF startup and UF Innovate | Sid Martin Biotech alum, for a new built-to-suit lab space on the heels of a federal government contract for the company to expand production capabilities, including vaccines and therapeutics for COVID-19 once finalized.

PanVent Emergency Ventilator Created to Fill Urgent Need During COVID-19

Dr. Samsun Lampotang has spent his career engineering solutions to medical problems. At the start of 2020, Lampotang’s focus was on designing, building and validating mixed reality guided intervention simulators to train physicians and nurses in medical procedures without putting patients at risk. But then COVID-19 changed all this.